Cutler Group’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-15,100
Closed -$14K 5077
2022
Q4
$14K Sell
15,100
-98,000
-87% -$1.66M ﹤0.01% 2501
2022
Q3
$36K Buy
113,100
+105,900
+1,471% +$1.66M ﹤0.01% 2159
2022
Q2
$2K Buy
+7,200
New +$61.9K ﹤0.01% 4445
2021
Q4
Sell
-6,000
Closed -$1K 6426
2021
Q3
$1K Sell
6,000
-5,300
-47% -$136K ﹤0.01% 5545
2021
Q2
$2K Buy
11,300
+4,000
+55% +$151K ﹤0.01% 5145
2021
Q1
$16K Buy
7,300
+2,700
+59% +$127K ﹤0.01% 3414
2020
Q4
$32K Sell
4,600
-6,000
-57% -$205K ﹤0.01% 2326
2020
Q3
$12K Buy
10,600
+800
+8% +$25.3K ﹤0.01% 2876
2020
Q2
$103K Sell
9,800
-4,600
-32% -$130K 0.01% 1284
2020
Q1
$23K Buy
+14,400
New +$316K ﹤0.01% 2221

Cutler Group's ONEM Position: Q1 2023 in Review

Cutler Group sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 27,507 shares — an estimated $459K sold.

Cutler Group first reported a position in ONEM in Q1 2020 and held it in 11 quarters. The position peaked at $459K in Q4 2022. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Cutler Group reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 27,507 1Life Healthcare shares in Q1 2023, an estimated $459K.
  • Cutler Group first reported a position in 1Life Healthcare in Q1 2020 and held it in 11 quarters.
  • Cutler Group's 1Life Healthcare position peaked at $459K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.